EC approves Bioepis' Humira biosimilar

Samsung Bioepis Co. Ltd. said the European Commission approved Imraldi (SB5), a

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE